Company Filing History:
Years Active: 2019
Title: Ranjana Tavorath: Innovator in Pharmaceutical Science
Introduction
Ranjana Tavorath is a notable inventor based in Basking Ridge, NJ (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative treatment methods for proliferative diseases. Her work exemplifies the intersection of scientific research and practical application in medicine.
Latest Patents
Ranjana Tavorath holds a patent for a dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor. This invention relates to methods of treating or preventing a proliferative disease in patients by orally administering a therapeutically effective amount of the compound. The regimen involves administering the compound for at least two five-consecutive day cycles, with specific intervals between cycles. This innovative approach aims to enhance the efficacy of treatment while minimizing side effects.
Career Highlights
Ranjana Tavorath is associated with Novartis AG, a leading global healthcare company. Her role at Novartis has allowed her to collaborate with other experts in the field, contributing to advancements in pharmaceutical research and development. Her dedication to improving patient outcomes through innovative therapies is evident in her work.
Collaborations
Ranjana has worked alongside esteemed colleagues such as Emmanuelle Di Tomaso and Marie-Caroline Germa. These collaborations have fostered a dynamic environment for research and innovation, leading to the development of effective treatment strategies.
Conclusion
Ranjana Tavorath's contributions to pharmaceutical science highlight her commitment to advancing medical treatments. Her innovative patent and collaborative efforts at Novartis AG underscore the importance of research in improving healthcare outcomes.